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Nutrigenomics is the study of how constituents of the diet interact with genes, and their products, to alter phenotype and, conversely, how genes and their
products metabolise these constituents into nutrients, antinutrients, and bioactive compounds. Results from molecular and genetic epidemiological studies
indicate that dietary unbalance can alter gene–nutrient interactions in ways that increase the risk of developing chronic disease. The interplay of human
genetic variation and environmental factors will make identifying causative genes and nutrients a formidable, but not intractable, challenge. We provide
specific recommendations for how to best meet this challenge and discuss the need for new methodologies and the use of comprehensive analyses of nutri-
ent–genotype interactions involving large and diverse populations. The objective of the present paper is to stimulate discourse and collaboration among
nutrigenomic researchers and stakeholders, a process that will lead to an increase in global health and wellness by reducing health disparities in developed
and developing countries.
Strategic international alliances: Nutrigenomics: Gene–nutrient interactions: Health diaparities
Genomes evolve in response to many types of environmental
stimuli, including nutrition. Therefore, the expression of genetic
information can be highly dependent on, and regulated by, nutri-
ents, micronutrients, and phytochemicals found in food. The study
of how genes and gene products interact with dietary chemicals to
alter phenotype and, conversely, how genes and their products
metabolise nutrients is called nutritional genomics or ‘nutrige-
nomics’. Unbalanced diets alter gene–nutrient interactions,
† This document is an outgrowth of the Bruce Ames International Symposium on Nutritional Genomics held at the University of California, Davis, CA on 22–24 October 2004.
The statements and opinions expressed are those of symposium participants and others who are contributing to nutrigenomics or related research fields. The present paper is
intended to stimulate discussion about the interplay of nutrition and genetics and the potential of nutrigenomics to improve global health.
* Corresponding author: Dr Jim Kaput, fax þ1 312 829 3357 email jkaput@uic.edu
Abbreviations: NuGO, European Nutrigenomics Organization; PROGENI, Program for Genetic Interaction; SNP, single nucleotide polymorphism.
British Journal of Nutrition (2005), 94, 623–632 DOI: 10.1079/BJN20051585
q The Authors 2005
thereby increasing the risk of developing chronic diseases. Differ-
ences in allele frequencies and DNA haplotype blocks within and
between human subpopulations, together with the chemical
complexity of food, make the study of nutrient–gene interactions
highly complex. Genetic variation and numerous environmental
influences put the study of these interactions beyond the scope
and expertise of any one researcher, institute or programme.
Additionally, systems biology approaches are necessary for ana-
lysing gene–environment interactions but they require disci-
pline-specific expertise and are expensive. Hence, there is
considerable justification for global sharing of knowledge. In the
present paper we provide an overview of the field of nutritional
genomics and specific recommendations regarding needs and
requirements for methodological advances and comprehensive
analyses of nutrient–genotype interactions in populations
throughout the world. The need for well-designed experiments
in model organisms and cell cultures is also discussed. The objec-
tive of the present paper is to initiate communication and collab-
oration among nutrigenomic researchers and stakeholders around
the world. By sharing ideas, best practices, and datasets, we hope
to identify synergies and create those breakthroughs needed to
develop more effective nutritional interventions and genome-
based dietary recommendations. Ultimately, an international con-
sortium will probably be necessary. We suggest a roadmap for
achieving this objective. This effort requires participation of
populations in many geographically distinct areas of the world.
We believe that developing collaborations and exchanging infor-
mation will have a significant, positive impact on health and
reduce health disparities in developed and developing countries.
Background
The shifting balance between health and disease states involves
the complex interplay of genes and the environment, which
includes diet. Most scientists acknowledge the importance of
environmental influences on the expression of genetic infor-
mation, yet many human, animal, and cell-culture studies over-
look their influences in their experimental designs (Kaput,
2004). At least two factors contribute to the genome-centric
view of current experimental strategies. First, in a 2001 report
summarising genes known to cause disease, 97 % of 923 genes
examined were found to be solely responsible for aberrant pheno-
types (Jimenez-Sanchez et al. 2001). Advances in our understand-
ing of the molecular mechanisms of monogenic diseases have led
to the implicit, if not explicit, belief that mutations are respon-
sible. However, even these monogenic diseases can vary in the
age of onset and in severity, demonstrating that other genetic or
environmental factors influence the expression of the causative
gene or its mutation. The second factor that contributes to gene-
centred research is the tremendous chemical complexity of
food. The simplest plant- and animal-derived foods contain hun-
dreds of chemical constituents, some of which are sources of
energy (for example, glucose or certain fatty acids), while
others serve as essential nutrients or regulators of cell functions
(for example, certain fatty acids and phyto-oestrogens such as
genistein). Consequently, diet is often overlooked as an important
variable in experimental design even though dietary constituents
can alter gene expression and/or gene structure. Two well-docu-
mented examples of how nutrient–gene interactions can affect
gene expression are provided by hyperforin and genistein. Hyper-
forin, the active ingredient in St John’s wort, binds to the ligand
binding site of the pregnane X receptor (Watkins et al. 2003) and
induces transcription of reporter genes in cell-culture systems
(Tirona et al. 2004; for a review, see Rebbeck et al. 2004). Gen-
istein, an isoflavone found in soya beans and other plants, binds to
the active site of oestrogen receptor b (Pike et al. 1999) and
induces oestrogen-specific gene expression in uteri of rats fed
genistein-supplemented food (Naciff et al. 2002). Recent reviews
discuss these and other molecular processes directly affected by
nutrients and show that nutrient–gene interactions affect health
(Jacobs & Lewis, 2002; Francis et al. 2003; Gillies, 2003;
Davis & Milner, 2004; Kaput & Rodriguez, 2004; Simopoulos
& Ordovas, 2004). Diet–gene interactions are complex and are
likely to require large populations for adequate statistical
power. Resolving experimental design issues that originate from
complexities of gene–environment interactions will probably
require pooling of information from several population groups.
Superimposed are technical challenges of clinical data collec-
tion from individuals of diverse cultures and ecosystems along
with the expense of complex phenotypic assessments and geno-
type analyses. Nutritional genomics requires a systems biology
approach, with the methods and technical skills ranging from gen-
otyping (especially single nucleotide polymorphism (SNP) anal-
ysis), nutritional epidemiology, microarray analysis, proteomics,
metabolomics, bioinformatics, pathology, and diverse clinical
assessments, in models ranging from cell culture to experimental
animals and human populations. Significant numbers of investi-
gators are developing nutrigenomics programmes in various
countries, and each of them will probably face similar problems
in developing and adapting cutting-edge technologies for high-
dimensional research efforts. The strategic and technical chal-
lenges of nutritional genomics justify the sharing of resources
and knowledge to avoid duplication in developing experimental
tools, software programs, and computational models.
Nutrition and human genetic diversity
Although there is a growing body of evidence demonstrating the
influence of some food constituents on gene activity, nutrige-
nomics must address how individual genomes respond to the
complex nutrient and chemical mixtures that comprise foods.
The sequencing of the human genome laid the foundation for
one of the most significant scientific contributions to humankind
– an evidence-based understanding that while human individuals
are genetically similar, each retains a unique genetic identity
underlying the wide array of biochemical, physiological, and mor-
phological phenotypes in human populations. However, genetic
variation produces a continuum for each human trait, thus chal-
lenging dichotomous social groupings based solely on external
phenotypes (Keita et al. 2004; Parra et al. 2004). Variation
among individuals from Africa, Asia, and Europe ranges from
10 % (analyses of simple tandem repeats) to 14 % (analyses of
Alu insertion polymorphisms). However, about 86–90 % of gen-
etic variation in our species is shared by ancestral groups (Jorde &
Wooding, 2004).
Genetic variation in populations confounds molecular epide-
miology studies that seek to analyse gene–disease or nutrient–
gene associations. For example, of the 603 gene–disease associ-
ations reported up to 2002, only six have been replicated more
than three times (Hirschhorn et al. 2002). Meta-analyses of
twenty-five different reported associations (data from 301 pub-
lished studies) showed statistically significant replication for
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eight gene associations (Lohmueller et al. 2003). Similarly, non-
replicated results associating diet with candidate gene variants are
the norm (for reviews, see Loktionov et al. 2000; Loktionov,
2003; Corella & Ordovas, 2004; Ordovas, 2004; Ordovas & Cor-
ella, 2004). In addition to population stratification, other confoun-
ders include sample sizes lacking statistical power,
inappropriately matched controls, overinterpretation of data
(Lander & Kruglyak, 1995; Risch, 1997; Cardon & Bell, 2001),
and the influence of other environmental factors (see later;
p. 629 of proof). There is a growing awareness that epistasis
(i.e. gene on gene interactions) (Hartman et al. 2001; Moore,
2003; Carlborg & Haley, 2004), genotype–environment inter-
actions particularly those involving diet (for reviews, see van
Ommen & Stierum, 2002; Corella & Ordovas, 2004; Kaput &
Rodriguez, 2004; Ordovas, 2004), and health status (for example,
Stoehr et al. 2000; Lan et al. 2003) may alter associations of SNP
or sets of SNP with disease processes. A lack of consistency in
methods of estimating food composition often precludes compari-
sons between populations. For example, estimates of dietary fibre
contents differ if they are defined and analysed as NSP, or accord-
ing to one of the more recent definitions (for example, Ferguson
& Harris, 2003; Devries, 2004). The combinations of study design
issues, complex and interacting molecular processes, and diverse
environmental influences demand a re-evaluation of how biome-
dical research is conducted.
Goals and objectives of nutritional genomics research
The purpose here is to stimulate communication and collaboration
among nutrigenomic researchers and stakeholders throughout the
world. Stakeholders include representatives from academia,
industry, government, and public interest groups. To help identify
synergies and create the breakthroughs needed to develop more
effective nutritional interventions and genome-based dietary rec-
ommendations, we are proposing discussions that will lead to
sharing ideas, datasets, research results, reagents, samples, and
best practices for conducting nutritional genomics research
under high scientific standards and in an ethical, socially respon-
sible, and culturally sensitive manner. The needs that have
been identified for nutritional genomics research are presented
(Muller & Kersten, 2003; Kaput, 2004; Ordovas & Corella,
2004).
Data federation
Development of a scalable database with semantic interoperabil-
ity that will allow sharing anonymised genetic, phenotypic, diet-
ary, nutritional status, and other environmental and cultural
information must have the highest priority. Semantic interoper-
ability will require agreements between independent database
developers that all systems share common ‘meanings’ of data
elements in a way that define a common ontology, mechanisms
to share common data elements, and a means to ‘harmonise’ defi-
nitional disagreements. Several biobanks have developed such
systems.
Larger study populations are needed
The statistical power of association studies needs to be increased
with common phenotypic measurements and combining results
from many studies. This can be a two-edged sword; in order to
detect the subtle effects of gene variants, large numbers of
study participants will be required. However, as the number of
individuals in a study increases, the greater the likelihood that
variance may be due to differences in environment and population
stratification. Stratification occurs when individuals within
the study population have different genetic architectures, which
arise from their ancestral lineage (for example, African v. Asian
ancestries). Analyses of genetic variance in human populations
show a greater variation within populations than between popu-
lations (for a review, see Jorde & Wooding, 2004). Hence, com-
bining data from multiple ancestral groups may reveal common
genotypes and responses to diet. Stratification may be a confoun-
der in standard statistical analyses because allele frequencies may
differ between populations (Reich & Goldstein, 2001; Freedman
et al. 2004). Genomic controls, such as analysing mitochondrial
DNA, Y chromosome, or autosomal (Jorgenson et al. 2005;
Tang et al. 2005) markers in participants, provide a measure of
population stratification. Dimensionality reduction algorithms
may identify clustering due to ancestral origins and associations
with groups of SNP and dietary composition.
Improving analyses and consistency of phenotypes
Early molecular epidemiology studies attempted to link one SNP
in a gene to a disease state such as cancer. However, variations in
different molecular pathways may produce the same phenotype or
disease. For example, type 2 diabetes mellitus is currently treated
by changing diet or exercise habits and/or by drugs that target
insulin secretion from the pancreas, glucose production by the
liver, glucose absorption by the intestine, or insulin resistance
by PPAR-targeted drugs in peripheral tissues (American Diabetes
Association, 2005). Patients respond differently to these treat-
ments or their combinations. Molecular epidemiologists include
disease markers such as insulin, glucose, and/or HDL-cholesterol
concentrations (rather than diabetes or atherosclerosis alone) to
identify ‘subphenotypes’ of disease. Clinical studies should
include repeated sampling and analyses that assess phenotypes
more accurately (Pereira et al. 2004). Since the molecular basis
for many diseases is lacking, the greater the number of accurate
clinical measurements analysed, the more powerful the study.
Since DNA samples may be shared across studies, common phe-
notypes for multiple diseases may be developed and measured
that would facilitate measurements across studies. For example,
serum HDL-cholesterol measurements could also be taken in
breast or colon cancer studies.
Capturing and assessing accurate food intakes
Food surveys and dietary histories are often inaccurate because of
differences in ability to recall specifics (type and amounts) of
food intakes and differences in dietary assessment methods (for
example, self-administered v. interviewed; food-frequency ques-
tionnaires v. diet diaries), and variations in their definitions and
analyses. A major emphasis of this international effort will there-
fore focus on standardising and improving dietary assessment
methodologies. Surveys will also have to capture self-described
affiliations to religions, cultures, customs, or ethnic groups
because of possible food restrictions and preferences. Confir-
mation of food intakes might also be accomplished by measuring
plasma micronutrient concentrations, assuming funds were avail-
able. In addition to accurate food intake information, databases
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are needed on the macro- and micronutrient content of local
foods, a challenge for the diverse cultures and diets throughout
the world. The FAO of the UN (Food and Agriculture Organiz-
ation, 2005) and various national governments have compiled
food composition tables for many countries worldwide, but data
must often be extracted from unlinked flat files or from publi-
cations. A relational database of food composition must be devel-
oped through international collaborations.
Genomic controls
More diverse genetic analyses, that include not only genetic variants
in nuclear DNA, but also analyses of mitochondrial DNA are needed.
When high throughput methods are further developed, chromosome
structure and DNA methylation analyses will also be needed.
Ethical and culturally sensitive recruitment
Ethical and culturally sensitive recruitment of study participants
from diverse cultures (International HapMap Consortium, 2004)
is needed. Some racial and ethnic populations and the poor
suffer disproportionately from chronic diseases and are likely
starting populations for nutrigenomic research. However, some
cultures and populations may be sceptical of molecular and gen-
etics disease research efforts, particularly because of colonial his-
tories. Addressing the legitimate concerns of these populations
will require the input of representatives from diverse communities
and cultures to develop standards of collaboration and communi-
cation with study participants. To our knowledge, there are no
precedents that allow for data sharing across national borders
yet protect individuals’ biological information (Austin et al.
2003; Maschke & Murray, 2004). Hence, among the first tasks
of the international effort will be to develop protocols for five cat-
egories of ethical, legal, and social issues: study sponsorship and
benefit sharing, public engagement, consent, and data protection
(see Austin et al. 2003). The participation of the international
nutrigenomic research community in addressing these issues
may help facilitate development of regional, national, and inter-
national policies for such research. Such efforts are scientifically
justified because comparative analyses among various ancestral
populations with different macro- and micronutrient intake
levels may be the critical approach to identify gene–nutrient
interactions involved in health and disease. Results from compar-
ing physiological and molecular responses between inbred strains
of experimental animals fed different defined, reproducible diets
identify gene–gene interactions and gene–environment inter-
actions (for example, Park et al. 1997; Kaput et al. 2004) that
cannot be revealed in homogeneous or genetically similar popu-
lations. Comparative analyses of different ancestral groups may
therefore reveal common as well as population-specific nutri-
ent–gene interactions (Tai & Tan, 2004).
Capturing the range of environmental variables
Capturing the range of environmental variables affecting expression
of genetic information is an essential component of comprehensive
gene–environment experiments and analyses. Although our pri-
mary focus is on nutrient–gene interactions, expression of genetic
information is influenced by numerous environmental factors. For
example, cytokine levels are unusually sensitive to environmental
changes and serve as good markers of environmental influences
that may alter protein and RNA expression. Some examples of
non-nutrient environmental factors are:
1. Overall sleep time and sleep continuity (for example, Red-
wine et al. 2000; Irwin, 2002);
2. O2 tension (Prabhakar & Peng, 2004), which is related to
altitude;
3. Over-the-counter drugs, for example, non-steroidal anti-
inflammatory drugs (Serhan et al. 2000);
4. Water intake relative to tea (Tomita et al. 2002) and other
beverages;
5. Physical activity, including genetic fitness to activity
(Nieman et al. 2003a,b, 2004; Gleeson et al. 2004);
6. Psychological factors such as stress (Irwin et al. 2003);
7. Exposure to allergens and pollutants (for example, Pandya
et al. 2002);
8. Circadian rhythm and seasonal changes (Albrecht & Eichele,
2003);
9. Balance between energy intake and expenditure (for a
review, see Seeley et al. 2004).
Each added variable may increase the need for larger popu-
lations since small studies may be unable to discriminate between
all environmental effects. However, meta-analyses may be poss-
ible if studies record similar data elements for their populations.
Although developing appropriate environmental survey instru-
ments is challenging, a set of guidelines and suggestions would
facilitate the development of common data elements for nutrige-
nomics studies.
Interactions between academia and industry
In the spirit of creating a truly integrated research initiative in
nutrigenomics, the interaction of partners from agriculture, food
processing, biotechnology, and pharmaceutical industries with
academic centres would accelerate technology development and
dissemination of nutrigenomic information to the public.
Examples include the development of new crop varieties with
enhanced nutritional value, novel food formulations and dietary
supplements that promote health and prevent disease, and the
development of chip-based diagnostic tests for monitoring
genome-specific dietary interventions. An excellent model for
this type of interaction is the recently awarded Freedom to
Discover grant from Bristol-Myers Squibb Company to the Pro-
gram in International Nutrition at the University of California
(Davis, 2005). The goal of this grant is to explore the implications
and applications of nutrigenomics and other ‘omics’ technologies
in developing countries. Establishing productive and mutually
beneficial relationships with industry for societal benefits and
the greater good is a goal shared by the members of the nutrige-
nomics research community. Addressing the issue of revenue
sharing among stakeholders, particularly study participants, will
be a high priority for the international nutrigenomics network.
One of many possible concepts is to develop novel agreements
that ensure revenue sharing with participants or communities
(Austin et al. 2003; Maschke & Murray, 2004) and, perhaps
more importantly, investments for economic development in
developing countries (Sachs, 2005).
Integration of nutrigenomics research
Nutrigenomic research depends upon robust and reliable methods
for discovering candidate genes for association analyses, and
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results of epidemiological associations that must be understood at
the molecular level. Reliable model systems are essential for the
development of an effective and successful international nutrige-
nomics effort. Examples of model systems that can provide valu-
able insights into molecular mechanisms underlying nutritional
genomics research are now described.
Cell culture
Nutrient interactions have been analysed in model systems
such as glucose deprivation (a model of energy restriction) in
Saccharomyces cerevisiae (for example, Lin et al. 2002; Lin &
Guarente, 2003) to human cells exposed to purified phytochem-
icals (for example, Pianetti et al. 2002) or micronutrients (for
example, folate (Kimura et al. 2004). Although genetic variation
is not typically analysed in such studies, cells in culture allow the
dissection of molecular pathways influenced by dietary chemicals.
Identifying diet-regulated or diet-influenced genes (and their pro-
ducts) using cell cultures allows for the analyses of gene variants
in human or animal studies.
Animal models
Cell cultures do not have livers, microflora in an alimentary tract,
nor the full metabolic repertoire of their complementary in vivo
counterparts. That is, metabolism and regulation of nutrient and
bioactive components of food are often affected by metabolism
and products in other organs. Animal studies are often necessary
to verify the results from cell-culture experiments. A distinct
advantage of using animal models is the array of genetically
defined mouse strains, the result of a 100-year effort to produce
and characterise inbred strains for biomedical research (Jackson
Laboratory, 2005). Laboratory animals are excellent models for
biomedical research. Comparative genomic analyses (for
example, Linder, 2001) have demonstrated that mice and rats
share genes and diseases that are similar in other mammals.
For example, 99 % of mouse genes have human homologues
(Waterston et al. 2002) and obesity-induced diabetes occurs in
mice (for example, Hribal et al. 2002; Rossmeisl et al. 2003)
and dogs (Fleeman & Rand, 2001). Molecular responses to
dietary chemicals can be analysed or compared in strains of
known genotypes with differing susceptibility to diet-induced
disease, enabling previously unsuspected contributors to the dis-
ease process to be identified (for example, Park et al. 1997;
Kaput et al. 2004). Breeding strategies permit identification of
epistatic interactions likely to influence gene–disease (Reifsnyder
et al. 2000; Cheverud et al. 2004) and nutrient–gene interactions
(for example, Cooney et al. 2002). Defined diets, which are repro-
ducible, are critical for diet–gene studies in experimental animals
(for example, Park et al. 1997; Kaput et al. 2004).
Studies in humans subjects
Ultimately, candidate genes from cell-culture systems or labora-
tory animals must be verified in human subjects. The two most
common methods are large-scale molecular epidemiological
studies and dietary cross-over trials. Ordovas & Corella (2004)
critically reviewed the methodology and progress of molecular
nutrigenomic epidemiological studies. Although such studies do
not prove causality, they provide statistical associations between
gene variants and disease, subphenotypes of disease, or changes
in physiology caused by diet. Since statistical association studies
are based on the analysis of groups or populations, the presence or
absence of a particular SNP in an individual may or may not be
linked to disease or response to diet. As mentioned previously,
dietary surveys or histories fail to accurately determine food
intake. Nevertheless, such association studies provide valuable
information linking genotype to phenotype. It is likely that
panels of SNP in different genes will be needed to improve the
probability that a set of gene variants is associated with a physio-
logical process or disease. Randomised double-blind (where poss-
ible) cross-over studies may be of value to confirm the validity of
nutrigenomics findings reported in genetic epidemiological
studies (for example, Dreon et al. 1999).
Models of scientific consortia
Interdisciplinary research is being fostered within institutions (Cech
& Rubin, 2004) and through national and international collabor-
ations. Four of these multi-institutional and national initiatives are
examples of collaborative efforts for nutritional genomics research.
The Pharmacogenetics and Pharmacogenomics Knowledge Base,
also known as PharmGKB, developed by Stanford University, is
funded by the National Institutes of Health and is part of a nation-
wide collaborative research consortium called the Pharmacoge-
netics Research Network (National Institute of General Medical
Services, 2005; Pharmacogenetics and Pharmacogenomics Knowl-
edge Base, 2005). PharmGKB is building a knowledge base with
accurate and detailed definitions of genotypes and phenotypes
involved in individual responses to different medications. Data are
generated by the US National Institutes of Health-funded projects in
twelve individual laboratories.
A second collaborative project is the Program for Genetic Inter-
action (PROGENI; Program for Genetic Interaction, 2005). PRO-
GENI is the Administrative and Data Coordinating Center for the
‘Interaction of Genes and Environment in Shaping Risk Factors
for Heart, Lung, Blood, and Sleep Disorders’ Study. Five separate
National Heart, Lung and Blood Institute-funded studies at differ-
ent locations (GET READI, GeneSTAR, GOLDN, GenSALT and
HAPI Heart) are coordinated through PROGENI, which also
pools data from the centres. Communication between subcommit-
tees are maintained and core issues shared by all studies are
addressed through the coordinating activities of the Center. The
subcommittees include Recruitment, Protection of Human Sub-
jects/Data Sharing, Phenotyping, Laboratory/DNA, Analysis and
an overarching Steering Committee. A Data Safety Management
Board, which is independent of and external to the Center, was
formed to critique protocols, oversee recruitment goals and
study progress. Biannual analysis workshops are held to bring
together statisticians, and experts in analytic techniques foster
cross-study collaboration and sharing of methods, tools, and
software.
Scientists from twenty-two organisations in the European
Union have formed the European Nutrigenomics Organization
(NuGO; www.nugo.org). Approximately 650 scientists belong
to this organisation with the key objective of development and
promotion of mechanistic nutrition and health research through
the application of ‘omics’ technologies. This is achieved through
the development of joint research programmes and stimulation of
facility sharing, facilitating education, communication, commer-
cialisation, and dissemination of information. Development, data
warehousing, and exploitation of nutrition- and health-related
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bioinformatics for European nutrition and nutrigenomics
researchers and communities are key issues. The formation of
NuGO is funded by the European Union. NuGO is fostering col-
laborations among members through targeted funding and an
interactive website, which hosts discussion groups on subjects
related to nutrigenomics research methods and results.
A fourth model of a collaborative project is the International
HapMap project (International HapMap Consortium, 2003, 2004),
which is analysing SNP patterns (haplotypes) of human genetic
variations within chromosomal regions. Each haplotype block
will be tagged or identified by one or more SNP. A use for this
resource will be association studies; candidate disease genes are
found within haplotype blocks more frequently associated with sub-
phenotypes of disease (for example, insulin levels or HDL-choles-
terol concentrations, etc) in individuals with symptoms compared
with individuals who are symptom-free. The HapMap Consortium
consists of committees dealing with: ethical, legal, and social
issues; population studies; community engagement and public con-
sultation; sample collection; genotyping and SNP analysis; SNP dis-
covery; scientific management and methods; initial planning
(International HapMap Consortium, 2004).
There are significant differences between these model colla-
borative projects and nutrigenomics research. Nutrigenomics
will require nutritional, cultural, and other environmental data
that may influence nutrient–gene interactions. Populations
linked to those variables also need to be identified. For example,
food intake and activity levels in urban areas may be significantly
different from those in rural areas. Macro- and micronutrient
intake levels may vary widely in rural populations because of cus-
toms and seasonal availability of different foods. Furthermore,
allele frequencies may differ between rural and urban populations
within the same country. Although it has been argued that SNP
associated with nutrient intakes have low penetrance and are unli-
kely to be predictive of disease susceptibility (Haga et al. 2003),
others contend that combinations of SNP in multiple disease-
linked genes will be predictive of a range of susceptibility to
chronic diseases (for example, Kaput, 2004). Nutrigenomic
studies will eventually resolve these conflicts. Nevertheless, the
identification of populations and the possibility of discovering
disease susceptibilities linked to genes, environment, and their
interactions bring into question ethical issues not faced by the
HapMap project, which seeks mainly to catalogue variations
rather than to link them with disease susceptibilities. It is our
view that these ethical issues can be resolved with appropriate
participation of individuals from different ethnicities and cultures
in conjunction with scientists and ethicists associated with this
nutrigenomics effort.
Roadmap
Ultimately, an international consortium will be necessary to effec-
tively harness the power of a large collaborative network of nutri-
tional genomics researchers with expertise, samples from
populations, experimental models, data, resources, and knowledge
of environment–gene interactions that affect health. Nutrige-
nomic initiatives are underway at many institutions and
companies throughout the world, many with disease- or nutri-
ent-specific foci. Hence, we recognise that additional stages of
communication and coordination are necessary for forming the
working consortium that harmonises plans and objectives to
avoid unnecessary replication of efforts.
The steps (Fig. 1) for developing an international effort for
nutritional genomics are the identification of researchers and
groups who define needs and resources at the local, national,
and regional efforts. NuGO is an example of a regional organis-
ation that may be emulated by national (for example, USA or
Canada) or regional efforts (North America or Africa or Asia).
Interested individuals from these organisations or laboratories
would then be organised into committees similar to those devel-
oped for the International HapMap Project. Parallel to this func-
tional grouping, regional nutrigenomics societies can be
founded to functionally stimulate and disseminate the science of
nutrigenomics. No barriers are foreseen in collaborating with
other national, regional, or international consortia focusing on
parallel scientific efforts. An international nutrigenomics consor-
tium would be a natural outgrowth of the coordinating group.
The resulting organisation would then hone goals, seek research
funding, develop research projects, educational tools and work-
shops, coordinate activities such as conference foci and dates,
and develop common data warehousing (Fig. 1).
Those of us involved with the development of the Pharmacoge-
netics Research Network (R. K.) or of NuGO (B. vO.) emphasise
the complexity of establishing strategic alliances at national
(USA) or regional (European) levels. These organisations required
approximately 4 years to develop and formalise, with significant
amounts of funding either from the US National Institutes of
Health or from the European Union, before reaching their current
productive state. International collaborations or the formation of a
nutrigenomics consortium will require time and funding. Some of
the steps that may be necessary are summarised in Fig. 1.
Conclusion
Nutritional genomics is a multi-disciplinary approach for the com-
prehensive investigation of the influence of diet and individual gen-
etic variation as risk factors for chronic disease. We understand that
certain genotypes are more severely affected by specific dietary fac-
tors than others (no genotype is free from the deleterious effects of
inadequate diet). Partnerships with academia, industry, and govern-
ment offer hope for identifying and characterising diet-regulated or
Fig. 1. Roadmap to an international nutrigenomics consortium. For details,
see p. 628.
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diet-influenced genes and genetic markers associated with chronic
diseases. Such knowledge is necessary, but not sufficient, to address
health disparities among all racial and ethnic populations through-
out the world. Social, economic and cultural factors are critical in
selecting foods and designing studies to identify causative genes
and interacting environmental factors. A comprehensive nutritional
genomics approach will yield short- and long-term benefits to
human health by: (i) revealing novel nutrient–gene interactions;
(ii) developing new diagnostic tests for adverse responses to diets;
(iii) identifying specific populations with special nutrient needs;
(iv) improving the consistency of current definitions and method-
ology related to dietary assessment; (v) providing the information
for developing more nutritious plant and animal foods and food for-
mulations that promote health and prevent, mitigate, or cure disease.
Achieving these goals will require extensive dialogue between
scientists and the public about the nutritional needs of the individual
v. groups, local food availability and customs, analysis and under-
standing of genetic differences between individuals and popu-
lations, and serious commitment of funds from the public and
private sectors. Nutritional genomics researchers are seeking
collaborations of scientists, scholars, and policy makers to
maximise the collective impact on global poverty and health by
advancing our knowledge of how genetics and nutrition can
promote health or cause disease.
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